Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

NCT00167908 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Ethyol (drug)

Sponsor

Washington University School of Medicine